Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Surgepays Inc (NASDAQ: SURG) was $2.18 for the day, down -7.23% from the previous closing price of $2.35. In other words, the price has decreased by -$7.23 from its previous closing price. On the day, 2.34 million shares were traded. SURG stock price reached its highest trading level at $2.37 during the session, while it also had its lowest trading level at $2.1001.
Ratios:
Our analysis of SURG’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.66 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.17.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 03 ’24 when Cox Kevin Brian sold 35,180 shares for $1.82 per share. The transaction valued at 64,084 led to the insider holds 5,770,090 shares of the business.
Evers Anthony George sold 36,666 shares of SURG for $68,199 on Dec 02 ’24. The Chief Financial Officer now owns 214,924 shares after completing the transaction at $1.86 per share. On Dec 03 ’24, another insider, KEVIN B COX, who serves as the Director of the company, bought 35,180 shares for $1.86 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SURG now has a Market Capitalization of 47379684 and an Enterprise Value of 37244832. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73 while its Price-to-Book (P/B) ratio in mrq is 2.86. Its current Enterprise Value per Revenue stands at 0.612 whereas that against EBITDA is -0.912.
Stock Price History:
The Beta on a monthly basis for SURG is 1.13, which has changed by -0.4452926 over the last 52 weeks, in comparison to a change of 0.08572841 over the same period for the S&P500. Over the past 52 weeks, SURG has reached a high of $4.38, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is 53.67%, while the 200-Day Moving Average is calculated to be 11.09%.
Shares Statistics:
SURG traded an average of 1.50M shares per day over the past three months and 8637280 shares per day over the past ten days. A total of 20.07M shares are outstanding, with a floating share count of 13.95M. Insiders hold about 30.82% of the company’s shares, while institutions hold 9.82% stake in the company. Shares short for SURG as of 1741910400 were 354179 with a Short Ratio of 0.24, compared to 1739491200 on 365762. Therefore, it implies a Short% of Shares Outstanding of 354179 and a Short% of Float of 2.4400001000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for Surgepays Inc (SURG) reflects the collective analysis of 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between $0.07 and $0.07 for the fiscal current year, implying an average EPS of $0.07.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $9.93M to a low estimate of $9.67M. As of the current estimate, Surgepays Inc’s year-ago sales were $31.43MFor the next quarter, 2 analysts are estimating revenue of $18.38M. There is a high estimate of $19.07M for the next quarter, whereas the lowest estimate is $17.69M.
A total of 3 analysts have provided revenue estimates for SURG’s current fiscal year. The highest revenue estimate was $136.04M, while the lowest revenue estimate was $91.59M, resulting in an average revenue estimate of $111.49M. In the same quarter a year ago, actual revenue was $60.88MBased on 1 analysts’ estimates, the company’s revenue will be $308.97M in the next fiscal year. The high estimate is $308.97M and the low estimate is $308.97M.
